Company news

Bio-Techne Corp news in 2025

Bio-Techne Corp's news releases, calls and decks from 2025, newest first.

View company

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

December 22, 2025

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

December 10, 2025

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

December 8, 2025

Evolve Announces Estimated Annual Distributions for Certain Evolve Funds

December 2, 2025

Bio-Techne to Present at Upcoming Investor Conferences

November 24, 2025

Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 19, 2025

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 17, 2025

Bio-Techne Releases First Quarter Fiscal 2026 Results

November 4, 2025

Bio-Techne declares dividend

November 4, 2025

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

November 3, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

November 3, 2025

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

October 27, 2025

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

October 23, 2025

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

October 14, 2025

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

October 8, 2025

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

September 25, 2025

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

September 23, 2025

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

August 14, 2025

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

August 5, 2025

Bio-Techne Announces Exosome Diagnostics Divestiture

August 4, 2025

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering

July 31, 2025

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

July 16, 2025

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

July 14, 2025

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

July 13, 2025

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

June 23, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

June 10, 2025

Bio-Techne to Present at Investor Conferences

May 28, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

May 13, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025

May 11, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

May 7, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

May 7, 2025

Bio-Techne releases third quarter fiscal 2025 results

May 6, 2025

Bio-Techne declares dividend and new share repurchase program

May 6, 2025

ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.

May 6, 2025

ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

April 29, 2025

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

April 23, 2025

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 22, 2025

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results

April 14, 2025

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

April 1, 2025

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

March 25, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

March 23, 2025

Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System

March 9, 2025

Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes

March 2, 2025

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

February 19, 2025

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

February 17, 2025

Bio-Techne Releases Second Quarter Fiscal 2025 Results

February 4, 2025

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

February 3, 2025

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

January 20, 2025

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

January 9, 2025

Bio-Techne to present at phacilitate advanced therapies week 2025

January 7, 2025

Older news releases →

Calls in 2025

Decks in 2025